Gene therapy for the treatment of peripheral vascular disease and coronary artery disease

Drugs of Today

Volumn 36, Issue 9, 2000, Pages 609-617

  Hedman, M ^a   Yla Herttuala, S ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CELL CYCLE PROTEIN; FIBROBLAST GROWTH FACTOR; GANCICLOVIR; GENE PRODUCT; GROWTH FACTOR; HEPATIC GROWTH FACTOR; NITRIC OXIDE SYNTHASE; PROTEIN ANTIBODY; PROTEIN BCL X; PROTEIN P53; THYMIDINE KINASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VIRUS VECTOR;

ANGIOPLASTY; ANIMAL EXPERIMENT; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CORONARY ARTERY OBSTRUCTION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; EXPRESSION VECTOR; GENE TARGETING; GENE THERAPY; GRAFT OCCLUSION; HOMEOBOX; HUMAN; MEDICAL ETHICS; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RESTENOSIS; RETINOBLASTOMA; REVIEW; TRANSGENE; TUMOR SUPPRESSOR GENE;

EID: 0033794308     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2000.36.9.593778     Document Type: Review

References (60)

1. Cardiovascular gene therapy
2. A new cationic liposome DNA complex enhances the efficiency of arterial gene transfer in vivo
3. Activation of the complement system by synthetic DNA complexes: A potential barrier for intravenous gene delivery
4. Efficient adventitial gene delivery to rabbit carotid artery with cationic polymer-plasmid complexes
5. A general method for the generation of high-titer, pantropic retroviral vectors: Highly efficient infection of primary hepatocytes
6. Adenovirus-mediated gene transfer into normal arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia
7. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors
8. Adenoviruses as gene-delivery vehicles
9. Vascular gene transfer
10. Anatomic barriers influence the distribution of in vivo gene transfer in the arterial wall
11. Low efficiency of percutaneous adenovirus-mediated arterial gene transfer in the atherosclerotic rabbit
12. Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery
13. Intracoronary heparin delivery in humans
14. Localized drug delivery in atherosclerotic arteries via a new balloon angioplasty catheter with intramural channels for simultaneous local drug delivery
15. Catheter-mediated VEGF gene transfer to human coronary arteries after angioplasty
16. T lymphocyte-directed gene therapy for ADASCID: Initial trial results after 4 years
17. A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia
18. 165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischaemia
19. Vascular endothelial growth factor: Gene therapy and therapeutic angiogenesis
20. 121 cDNA to individuals with clinically significant severe coronary artery disease
21. Induction of neoangiogenesis in ischemic myocardium by human growth factors: First clinical results of a new treatment of coronary heart disease
22. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: Results of a phase I randomized, double-blind, placebo-controlled trial
23. Intrapericardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischemia
24. Efficient in vivo catheter-based pericardial gene transfer mediated by adenoviral vectors
25. Coronary stents
26. Management of peripheral vascular disease: Innovative approaches using radiation therapy
27. 2 in endothelial cells via p42/p44 mitogen activated protein kinase
28. Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium
29. VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries
30. Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb
31. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart
32. Adenovirus-mediated expression of the secreted form of basic fibroblast growth factor (FGF-2) induces cellular proliferation and angiogenesis in vivo
33. Arterial gene transfer of acidic fibroblast growth factor for therapeutic angiogenesis in vivo: Critical role of secretion signal in use of naked DNA
34. Recombinant fibroblast frowth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo
35. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: The case of paracrine amplification of angiogenesis
36. Contribution of a vascular modulator, hepatocyte growth factor (HGF), to the pathogenesis of cardiovascular disease
37. Gene therapy for vascular smooth muscle cell proliferation after arterial injury
38. Adenovirus-mediated overexpression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty
39. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product
40. Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease
41. Transfer of wild-type p53 gene effectively inhibits vascular smooth cell proliferation in vitro and in vivo
42. The role of proto-oncogenes in coronary restenosis
43. Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: The PREVENT single-centre, randomized, controlled trial
44. P21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene
45. Embryonic expression of the Gax homeodomain protein in cardiac, smooth, and skeletal muscle
46. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis
47. Gene therapy inhibiting neointimal vascular lesion: In vivo transfer of endothelial cell nitric oxide synthase gene
48. Expression and function of recombinant endothelial NO synthase in coronary artery smooth muscle cells
49. Substantial inhibition of neointimal response to balloon injury in the rat carotid artery using a combination of antibodies to platelet-derived growth factor-BB and basic fibroblast growth factor
50. Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischaemia
51. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb
52. Treatment of thrombangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: Preliminary clinical results
53. Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia
54. Catheter-mediated VEGF gene transfer to human lower limb arteries after PTA
55. Virus treatment questioned after gene therapy death
56. Biodistribution of adenoviral vector to non-target tissues after local in vivo gene transfer to arterial wall using intravascular and periadventitial gene delivery methods
57. Gene transfer into the carotid artery using an adventitial collar: Comparison of the effectiveness of the plasmid-liposome complexes, retroviruses, pseudotyped retroviruses, and adenoviruses
58. Dendrimer: Dream molecules approach real applications
59. Gene delivery: A single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus
60. Improving adenoviral vectors for cancer therapy